ARTICLE | Clinical News
PEG-Intron pegylated interferon-alpha-2b regulatory update
March 26, 2001 8:00 AM UTC
The FDA granted priority review status to an sBLA from ENZN partner Schering-Plough Corp. (SGP, Kenilworth, N.J.) for PEG-Intron powder for injection in combination with Rebetol ribavirin capsules t...